ArticleFrontiers in computational neuroscience2025
A new method for identifying and evaluating depressive disorders in young people based on cognitive neurocomputing: an exploratory study.
Article in Frontiers in computational neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depressive disorders are one of the most common mental disorders among young people. However, there is still a lack of objective means to identify and evaluate young people with depressive disorders quickly. Cognitive impairment is one of the core characteristics of depressive disorders, which is of great value in the identification and evaluation of young people with depressive disorders. Methods: This study proposes a new method for identifying and evaluating depressive disorders in young people based on cognitive neurocomputing. The method evaluates cognitive impairments such as reduced attention, executive dysfunction, and slowed information processing speed that may exist in the youth depressive disorder population through an independently designed digital evaluation paradigm. It also mines digital biomarkers that can effectively identify these cognitive impairments. A total of 50 young patients with depressive disorders and 47 healthy controls were included in this study to validate the method's identification and evaluation capability. Results: The differences analysis results showed that the digital biomarkers of cognitive function on attention, executive function, and information processing speed extracted in this study were significantly different between young depressive disorder patients and healthy controls. Through stepwise regression analysis, four digital biomarkers of cognitive function were finally screened. The area under the curve for them to jointly distinguish patients with depressive disorders from healthy controls was 0.927. Conclusion: This new method rapidly characterizes and quantifies cognitive impairment in young people with depressive disorders. It provides a new way for organizations, such as schools, to quickly identify and evaluate the population of young people with depressive disorders based on human-computer interaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.